DOI QR코드

DOI QR Code

Anti-inflammatory and antifatigue effect of Korean Red Ginseng in patients with nonalcoholic fatty liver disease

  • Hong, Meegun (Department of Internal Medicine, Hallym University College of Medicine) ;
  • Lee, Yoon Hyeong (Department of Internal Medicine, Hallym University College of Medicine) ;
  • Kim, Seungwoo (Department of Biomedical Science, Hallym University College of Medicine) ;
  • Suk, Ki Tae (Department of Internal Medicine, Hallym University College of Medicine) ;
  • Bang, Chang Seok (Department of Internal Medicine, Hallym University College of Medicine) ;
  • Yoon, Jai Hoon (Department of Internal Medicine, Hallym University College of Medicine) ;
  • Baik, Gwang Ho (Department of Internal Medicine, Hallym University College of Medicine) ;
  • Kim, Dong Joon (Department of Internal Medicine, Hallym University College of Medicine) ;
  • Kim, Myong Jo (College of Agriculture and Life Science, Kangwon National University)
  • Received : 2015.03.18
  • Accepted : 2015.07.24
  • Published : 2016.07.15

Abstract

Background: Korean Red Ginseng (KRG) is a well-known natural product with anticarcinogenic and antioxidant effects. We evaluated the antifatigue effect of KRG in patients with nonalcoholic fatty liver disease (NAFLD). Methods: Eighty patients with NAFLD were prospectively randomized to receive 3 wk of KRG or placebo in addition to counseling on healthy eating and regular exercise. Liver function test, proinflammatory cytokines, adiponectin, antioxidant activity, and fatigue score were measured and compared according to the body mass index between the KRG and placebo groups. Results: The liver function tests were significantly improved after 3 wk of treatment in both groups. The mean levels (at baseline and after treatment) of tumor necrosis factor-${\alpha}$ were $108.0pg/mL{\pm}54.8pg/mL$ and $92.7pg/mL{\pm}39.0pg/mL$ (p = 0.018) in the KRG group and $123.1pg/mL{\pm}42.1pg/mL$ and $127.5pg/mL{\pm}62.2pg/mL$ (p = 0.694) in the placebo group, respectively. There was a significant difference in change of adiponectin levels between the KRG ($7,751.2pg/mL{\pm}3,108.1pg/mL$ and $8,197.3pg/mL{\pm}2,714.5pg/mL$) and placebo groups ($7,711.6pg/mL{\pm}3,041.3pg/mL$ and $7,286.1pg/mL{\pm}5,188.7pg/mL$, p = 0.027). In patients with overweight, the fatigue score was significantly decreased in the KRG group ($35.0{\pm}13.2$ and $24.5{\pm}8.9$, p = 0.019). Conclusion: Our results show that KRG might be effective in reducing proinflammatory cytokine and fatigue in overweight patients with NAFLD, in addition to improvements in adiponectin levels.

Keywords

References

  1. Brunt EM. Nonalcoholic fatty liver disease: what the pathologist can tell the clinician. Dig Dis 2012;30:61-8. https://doi.org/10.1159/000341127
  2. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313-21. https://doi.org/10.1002/hep.20701
  3. Review Team, LaBrecque DR, Abbas Z, Anania F, Ferenci P, Khan AG, Goh KL, Hamid SS, Isakov V, Lizarzabal M, et al. World Gastroenterology Organisation global guidelines: nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. J Clin Gastroenterol 2014;48:467-73.
  4. Newton JL, Jones DE, Henderson E, Kane L, Wilton K, Burt AD, Day CP. Fatigue in non-alcoholic fatty liver disease (NAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease severity or insulin resistance. Gut 2008;57:807-13. https://doi.org/10.1136/gut.2007.139303
  5. Morris G, Berk M, Walder K, Maes M. Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses. BMC Med 2015;13:28. https://doi.org/10.1186/s12916-014-0259-2
  6. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, Natale S, Vanni E, Villanova N, Melchionda N, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003;37:917-23. https://doi.org/10.1053/jhep.2003.50161
  7. Scalera A, Tarantino G. Could metabolic syndrome lead to hepatocarcinoma via non-alcoholic fatty liver disease? World J Gastroenterol 2014;20:9217-28.
  8. Jarosz PA, Davis JE, Yarandi HN, Farkas R, Feingold E, Shippings SH, Smith AL, Williams D. Obesity in urban women: associations with sleep and sleepiness, fatigue and activity. Womens Health Issues 2014;24:e447-54. https://doi.org/10.1016/j.whi.2014.04.005
  9. Hong SH, Suk KT, Choi SH, Lee JW, Sung HT, Kim CH, Kim EJ, Kim MJ, Han SH, Kim MY, et al. Anti-oxidant and natural killer cell activity of Korean Red Ginseng (Panax ginseng) and urushiol (Rhus vernicifera Stokes) on nonalcoholic fatty liver disease of rat. Food Chem Toxicol 2013;55:586-91. https://doi.org/10.1016/j.fct.2013.01.022
  10. Bang CS, Hong SH, Suk KT, Kim JB, Han SH, Sung H, Kim EJ, Kim MJ, Kim MY, Baik SK, et al. Effects of Korean Red Ginseng (Panax ginseng), urushiol (Rhus vernicifera Stokes), and probiotics (Lactobacillus rhamnosus R0011 and Lactobacillus acidophilus R0052) on the gut-liver axis of alcoholic liver disease. J Ginseng Res 2014;38:167-72. https://doi.org/10.1016/j.jgr.2014.04.002
  11. Shen L, Xiong Y, Wang DQ, Howles P, Basford JE, Wang J, Xiong YQ, Hui DY, Woods SC, Liu M. Ginsenoside Rb1 reduces fatty liver by activating AMP-activated protein kinase in obese rats. J Lipid Res 2013;54:1430-8. https://doi.org/10.1194/jlr.M035907
  12. Barton DL, Liu H, Dakhil SR, Linquist B, Sloan JA, Nichols CR, McGinn TW, Stella PJ, Seeger GR, Sood A, et al. Wisconsin Ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2. J Natl Cancer Inst 2013;105:1230-8. https://doi.org/10.1093/jnci/djt181
  13. Ginseng helps cancer-related fatigue. Mayo Clin Health Lett 2012;30:4.
  14. Choi JY, Woo TS, Yoon SY, Ike Campomayor Dela P, Choi YJ, Ahn HS, Lee YS, Yu GY, Cheong JH. Red ginseng supplementation more effectively alleviates psychological than physical fatigue. J Ginseng Res 2011;35:331-8. https://doi.org/10.5142/jgr.2011.35.3.331
  15. Katz P, Margaretten M, Trupin L, Schmajuk G, Yazdany J, Yelin E. Sleep disturbance, depression, obesity, and physical inactivity explain a significant portion of fatigue in rheumatoid arthritis. Arthritis Care Res 2016;68:81-90. https://doi.org/10.1002/acr.22577
  16. Brainina KhZ, Ivanova AV, Sharafutdinova EN, Lozovskaya EL, Shkarina EI. Potentiometry as a method of antioxidant activity investigation. Talanta 2007;71:13-8. https://doi.org/10.1016/j.talanta.2006.03.018
  17. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989;46:1121-3. https://doi.org/10.1001/archneur.1989.00520460115022
  18. Kim HG, Cho JH, Yoo SR, Lee JS, Han JM, Lee NH, Ahn YC, Son CG. Antifatigue effects of Panax ginseng C.A. Meyer: a randomised, double-blind, placebocontrolled trial. PloS One 2013;8:e61271. https://doi.org/10.1371/journal.pone.0061271
  19. Jin YJ, Kim KM, Hwang S, Lee SG, Ha TY, Song GW, Jung DH, Kim KH, Yu E, Shim JH, et al. Exercise and diet modification in non-obese non-alcoholic fatty liver disease: analysis of biopsies of living liver donors. J Gastroenterol Hepatol 2012;27:1341-7. https://doi.org/10.1111/j.1440-1746.2012.07165.x
  20. Promrat K, Kleiner DE, Niemeier HM, Jackvony E, Kearns M, Wands JR, Fava JL, Wing RR. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 2010;51:121-9. https://doi.org/10.1002/hep.23276
  21. Ball KR, Kowdley KV. A review of Silybum marianum (milk thistle) as a treatment for alcoholic liver disease. J Clin Gastroenterol 2005;39:520-8. https://doi.org/10.1097/01.mcg.0000165668.79530.a0
  22. Shaker E, Mahmoud H, Mnaa S. Silymarin, the antioxidant component and Silybum marianum extracts prevent liver damage. Food Chem Toxicol 2010;48:803-6. https://doi.org/10.1016/j.fct.2009.12.011
  23. Niranjana Murthy H, Dandin VS, Yoeup Paek K. Hepatoprotective activity of ginsenosides from Panax ginseng adventitious roots against carbon tetrachloride treated hepatic injury in rats. J Ethnopharmacol 2014;158:442-6. https://doi.org/10.1016/j.jep.2014.10.047
  24. Zhang SS, Wu ZY, Chen JM, Guo QK, Li L, Wang ZF, Gao Y, Ma ZC. Study on the mechanism of action of total saponins of Panax notoginseng in ameliorating oxidative stress and insulin resistance in rats fed with high fat diet. Zhongguo Zhong Xi Yi Jie He Za Zhi 2014;34:56-61.
  25. Seo SJ, Cho JY, Jeong YH, Choi YS. Effect of Korean Red Ginseng extract on liver damage induced by short-term and long-term ethanol treatment in rats. J Ginseng Res 2013;37:194-200. https://doi.org/10.5142/jgr.2013.37.194
  26. Lihn AS, Pedersen SB, Richelsen B. Adiponectin: action, regulation and association to insulin sensitivity. Obes Rev 2005;6:13-21. https://doi.org/10.1111/j.1467-789X.2005.00159.x
  27. Yeo CR, Yang C, Wong TY, Popovich DG. A quantified ginseng (Panax ginseng C.A. Meyer) extract influences lipid acquisition and increases adiponectin expression in 3T3-L1 cells. Molecules 2011;16:477-92. https://doi.org/10.3390/molecules16010477
  28. Song YB, An YR, Kim SJ, Park HW, Jung JW, Kyung JS, Hwang SY, Kim YS. Lipid metabolic effect of Korean Red Ginseng extract in mice fed on a high-fat diet. J Sci Food Agric 2012;92:388-96. https://doi.org/10.1002/jsfa.4589
  29. Quan HY, Kim do Y, Chung SH. Korean Red Ginseng extract alleviates advanced glycation end product-mediated renal injury. J Ginseng Res 2013;37:187-93. https://doi.org/10.5142/jgr.2013.37.187
  30. Zhao J, Shi Z, Liu S, Li J, Huang W. Ginsenosides Rg1 from Panax ginseng: a potential therapy for acute liver failure patients? Evid Based Complement Alternat Med 2014;2014:538059.
  31. Cho YJ, Son HJ, Kim KS. A 14-week randomized, placebo-controlled, double-blind clinical trial to evaluate the efficacy and safety of ginseng polysaccharide (Y-75). J Transl Med 2014;12:283. https://doi.org/10.1186/s12967-014-0283-1
  32. Berg AH, Combs TP, Scherer PE. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 2002;13:84-9. https://doi.org/10.1016/S1043-2760(01)00524-0
  33. Fan JS, Liu DN, Huang G, Xu ZZ, Jia Y, Zhang HG, Li XH, He FT. Panax notoginseng saponins attenuate atherosclerosis via reciprocal regulation of lipid metabolism and inflammation by inducing liver X receptor alpha expression. J Ethnopharmacol 2012;142:732-8. https://doi.org/10.1016/j.jep.2012.05.053
  34. Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines: management of nonalcoholic fatty liver disease. Clin Mol Hepatol 2013;19:325-48. https://doi.org/10.3350/cmh.2013.19.4.325

Cited by

  1. Ginsenosides analysis in the crude saponin fraction extracted from Korean red ginseng, and its efficacious analysis against acute pulmonary inflammation in mice vol.30, pp.3, 2016, https://doi.org/10.5806/ast.2017.30.3.146
  2. Alcohol extract of North American ginseng (Panax quinquefolius) reduces fatty liver, dyslipidemia, and other complications of metabolic syndrome in a mouse model vol.95, pp.9, 2016, https://doi.org/10.1139/cjpp-2016-0510
  3. Ginsenoside Rg3 Decreases Fibrotic and Invasive Nature of Endometriosis by Modulating miRNA-27b: In Vitro and In Vivo Studies vol.7, pp.None, 2016, https://doi.org/10.1038/s41598-017-17956-0
  4. Investigation of Herb-Drug Interactions between Korean Red Ginseng Extract and five CYP Substrates by LC-MS/MS vol.8, pp.4, 2016, https://doi.org/10.5478/msl.2017.8.4.98
  5. Beneficial Effects of Korean Red Ginseng in the Progression of Non-Alcoholic Steatohepatitis via FABP4 Modulation vol.46, pp.7, 2016, https://doi.org/10.1142/s0192415x18500817
  6. Panax ginseng for Frailty-Related Disorders: A Review vol.5, pp.None, 2016, https://doi.org/10.3389/fnut.2018.00140
  7. Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD vol.6, pp.3, 2016, https://doi.org/10.3390/diseases6030080
  8. Effects of ginseng supplementation on selected markers of inflammation: A systematic review and meta‐analysis vol.33, pp.8, 2016, https://doi.org/10.1002/ptr.6399
  9. Medicinal plants in traumatic brain injury: Neuroprotective mechanisms revisited vol.45, pp.4, 2016, https://doi.org/10.1002/biof.1516
  10. Anti-Inflammatory Diets and Fatigue vol.11, pp.10, 2019, https://doi.org/10.3390/nu11102315
  11. Red ginseng extract regulates differentiation of monocytes to macrophage and inflammatory signalings in human monocytes vol.28, pp.6, 2016, https://doi.org/10.1007/s10068-019-00611-x
  12. Fermented Korean Red Ginseng Extract Enriched in Rd and Rg3 Protects against Non-Alcoholic Fatty Liver Disease through Regulation of mTORC1 vol.11, pp.12, 2019, https://doi.org/10.3390/nu11122963
  13. A 12-week, randomized, double-blind study to evaluate the efficacy and safety of liver function after using fermented ginseng powder (GBCK25) vol.64, pp.None, 2020, https://doi.org/10.29219/fnr.v64.3517
  14. Herbal Medicine in the Treatment of Non-Alcoholic Fatty Liver Diseases-Efficacy, Action Mechanism, and Clinical Application vol.11, pp.None, 2016, https://doi.org/10.3389/fphar.2020.00601
  15. Korean red ginseng for cancer-related fatigue in colorectal cancer patients with chemotherapy: A randomised phase III trial vol.130, pp.None, 2016, https://doi.org/10.1016/j.ejca.2020.02.018
  16. Comparative transcriptome analysis of the protective effects of Korean Red Ginseng against the influence of bisphenol A in the liver and uterus of ovariectomized mice vol.44, pp.3, 2020, https://doi.org/10.1016/j.jgr.2020.01.008
  17. Characterization of red ginseng–drug interaction by CYP3A activity increased in high dose administration in mice vol.41, pp.7, 2016, https://doi.org/10.1002/bdd.2246
  18. Effect of Korean Red Ginseng on Cholesterol Metabolites in Postmenopausal Women with Hypercholesterolemia: A Pilot Randomized Controlled Trial vol.12, pp.11, 2016, https://doi.org/10.3390/nu12113423
  19. Herbal formulation MIT ameliorates high-fat diet-induced non-alcoholic fatty liver disease vol.9, pp.4, 2016, https://doi.org/10.1016/j.imr.2020.100422
  20. Hepatic steatosis integrated approach: nutritional guidelines and joined nutraceutical administration vol.66, pp.4, 2020, https://doi.org/10.23736/s1121-421x.20.02738-5
  21. Effect of Korean Red Ginseng on metabolic syndrome vol.45, pp.3, 2016, https://doi.org/10.1016/j.jgr.2020.11.002
  22. Design of Hepatic Targeted Drug Delivery Systems for Natural Products: Insights into Nomenclature Revision of Nonalcoholic Fatty Liver Disease vol.15, pp.11, 2016, https://doi.org/10.1021/acsnano.1c02158
  23. Characterization of hyperglycemia due to sub-chronic administration of red ginseng extract via comparative global proteomic analysis vol.11, pp.1, 2016, https://doi.org/10.1038/s41598-021-91664-8
  24. It Is High Time Physicians Thought of Natural Products for Alleviating NAFLD. Is There Sufficient Evidence to Use Them? vol.22, pp.24, 2016, https://doi.org/10.3390/ijms222413424